Effect of radiotherapy on survival in advanced hepatocellular carcinoma patients treated with sorafenib: a nationwide cancer-registry-based study

Sorafenib is the standard treatment for advanced hepatocellular carcinoma (HCC) patients. This study aims to determine whether combining radiotherapy with sorafenib administration increases its efficacy. The study cohort included 4763 patients with diagnosed advanced HCC who received sorafenib betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Shou-Sheng, Kuo, Yu-Hsuan, Liu, Wen-Shan, Wang, Shih-Chang, Ho, Chung-Han, Chen, Yi-Chen, Yang, Ching-Chieh, Wu, Hung-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810734/
https://www.ncbi.nlm.nih.gov/pubmed/33452421
http://dx.doi.org/10.1038/s41598-021-81176-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810734/
https://www.ncbi.nlm.nih.gov/pubmed/33452421
http://dx.doi.org/10.1038/s41598-021-81176-w

Ejemplares similares